General MedicationsINTRAVENOUSStandard
LINEZOLID
LINEZOLID
Standard Dose
600MG/300ML (2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LINEZOLID is listed in Drugs@FDA under application 219558 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LINEZOLID Form and strength SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML) Sponsor CAPLIN Submission history Latest submission status date: 2025-12-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview LINEZOLID is listed in Drugs@FDA under application 219558 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LINEZOLID Form and strength SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML) Sponsor CAPLIN Submission history Latest submission status date: 2025-12-08 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.